美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ImageneBio, Inc.

14.75

+0.55003.87%

成交量：2,968.00

成交额：4.29万

市值：1.65亿

市盈率：-1.42

高：15.27

开：14.35

低：14.30

收：14.20

52周最高：23.28

52周最低：11.65

股本：1,118.17万

流通股本：619.93万

量比：0.57

换手率：0.05%

股息：- -

股息率：- -

每股收益(TTM):-10.3710

每股收益(LYR):-12.2427

净资产收益率：--

总资产收益率：--

市净率：-0.87

市盈率(LYR):-1.20

数据加载中...

总览公司新闻公告

公司资料

公司名字：

ImageneBio, Inc.

交易所：

NASDAQ

成立时间：

- -

员工人数：

9

公司地址：

12526 High Bluff Drive,Suite 345,San Diego,California,United States

官网：

http://www.inmagenebio.com

邮编：

92130

电话：

传真：

- -

简介：

ImageneBio, Inc.于2016年3月2日成立为特拉华州公司，总部位于马萨诸塞州波士顿。该公司是一家靶向肿瘤公司，专注于开发针对驱动癌症形成和扩散的关键信号通路的新型癌症疗法。该公司的项目专注于关键的癌症驱动途径，这些途径在科学文献中得到了很好的验证，但缺乏经批准或有效的治疗方法，因此有可能解决高度未满足的医疗需求。通过利用对发现化学、转化科学和以患者为中心的药物开发的深刻理解，该公司建立了一个专注于基因定义或生物标记物驱动的癌症的全资和合作项目的深入渠道，能够针对该公司认为最有可能的特定患者群体对候选产品的治疗作出反应。自2016年开始运营以来，该公司已经发现或开发了5个肿瘤项目，其中包括4个IND研究或临床开发的候选产品。

董事

名称

职位

Kristin Yarema

Chief Executive Officer and Director

David Bonita

Director

Jonathan Jian Wang

Director

Otello Stampacchia

Director

Stephen Hui Wang

Director

Weiguo Su

Director

股东

名称

职位

Kristin Yarema

Chief Executive Officer and Director

Erin Butler

Senior Vice President, Finance and Administration and Principal Accounting Officer

Jotin Marango

Chief Financial Officer and Corporate Secretary

Yufang Lu

Chief Medical Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IMA/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"IMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMA\",,,,,undefined,":{"symbol":"IMA","market":"US","secType":"STK","nameCN":"ImageneBio, Inc.","latestPrice":14.75,"timestamp":1755542262134,"preClose":14.2,"halted":0,"volume":2968,"delay":0,"floatShares":6199299,"shares":11181700,"eps":-10.370976,"marketStatus":"交易中","change":0.55,"latestTime":"08-18 14:46:51 EDT","open":14.35,"high":15.2654,"low":14.3,"amount":42899.534327999994,"amplitude":0.067986,"askPrice":14.75,"askSize":993,"bidPrice":14.27,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-10.370976,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1755547200000},"marketStatusCode":2,"adr":0,"listingDate":1616731200000,"exchange":"NASDAQ","adjPreClose":14.2,"postHourTrading":{"tag":"盘后","latestPrice":14.2,"preClose":14.2,"latestTime":"18:11 EDT","volume":20,"amount":290.84,"timestamp":1755295917709},"volumeRatio":0.568572},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMA\",,,,,undefined,":{"symbol":"IMA","floatShares":6199299,"roa":"--","roe":"--","lyrEps":-12.242664,"volumeRatio":0.568572,"shares":11181700,"dividePrice":0,"high":15.2654,"amplitude":0.067986,"preClose":14.2,"low":14.3,"week52Low":11.6484,"pbRate":"-0.87","psRate":"38.36","week52High":23.28,"institutionHeld":0,"latestPrice":14.75,"committee":-0.997988,"eps":-10.370976,"divideRate":0,"volume":2968,"delay":0,"ttmEps":-10.370976,"open":14.35,"prevYearClose":19.68,"prevWeekClose":14.2,"prevMonthClose":17.9,"prevQuarterClose":16.08,"fiveDayClose":14.74,"twentyDayClose":15.24,"sixtyDayClose":13.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-28","symbol":"IMA","defaultRemindTime":1753709400000,"type":"split","dateTimestamp":1753675200000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2025-07-24","symbol":"IMA","fiscalQuarterEnding":"2025/06","expectedEps":-0.14,"name":null,"time":"盘后","type":"earning","dateTimestamp":1753329600000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2025-05-08","symbol":"IMA","fiscalQuarterEnding":"2025/03","expectedEps":-0.21,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2025-03-06","symbol":"IMA","fiscalQuarterEnding":"2024/12","expectedEps":-0.19,"name":null,"time":"盘前","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2024-11-07","symbol":"IMA","fiscalQuarterEnding":"2024/09","expectedEps":-0.27,"name":null,"time":"盘前","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.19}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0,"analysts":2,"updateTime":1716955200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMA","date":"2025-08-15","current":-8.134224,"percent":0,"low":-8.134224,"twenty":-8.112228,"median":-8.06823,"eighty":-8.016532,"high":-7.809739,"avg":-8.03743,"sd":0.116543,"marketCap":165376899},"quantilePoints":[{"date":"2025-08-15","current":-8.134224,"twenty":-8.112228,"median":-8.06823,"eighty":-8.016532,"marketCap":165376899}],"updateTime":1755542811353},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":689254445,"employeeNum":9,"address":"12526 High Bluff Drive,Suite 345,San Diego,California,United States","zipCode":"92130","officePhone":"617-901-7098"},"stockCompanyDetail":{"websiteUrl":"http://www.inmagenebio.com","stockEarnings":[{"period":"1week","weight":-0.032},{"period":"1month","weight":-0.0827},{"period":"3month","weight":0.0661},{"period":"6month","weight":-0.2058},{"period":"1year","weight":-0.2956},{"period":"ytd","weight":-0.2785}],"compareEarnings":[{"period":"1week","weight":0.0098},{"period":"1month","weight":0.0308},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1634},{"period":"ytd","weight":0.0979}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ImageneBio, Inc.于2016年3月2日成立为特拉华州公司，总部位于马萨诸塞州波士顿。该公司是一家靶向肿瘤公司，专注于开发针对驱动癌症形成和扩散的关键信号通路的新型癌症疗法。该公司的项目专注于关键的癌症驱动途径，这些途径在科学文献中得到了很好的验证，但缺乏经批准或有效的治疗方法，因此有可能解决高度未满足的医疗需求。通过利用对发现化学、转化科学和以患者为中心的药物开发的深刻理解，该公司建立了一个专注于基因定义或生物标记物驱动的癌症的全资和合作项目的深入渠道，能够针对该公司认为最有可能的特定患者群体对候选产品的治疗作出反应。自2016年开始运营以来，该公司已经发现或开发了5个肿瘤项目，其中包括4个IND研究或临床开发的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.009984},{"month":2,"riseRate":0.25,"avgChangeRate":-0.11454},{"month":3,"riseRate":0,"avgChangeRate":-0.048264},{"month":4,"riseRate":0.2,"avgChangeRate":0.002486},{"month":5,"riseRate":0.6,"avgChangeRate":0.039135},{"month":6,"riseRate":0.6,"avgChangeRate":-0.001759},{"month":7,"riseRate":0.6,"avgChangeRate":-0.047104},{"month":8,"riseRate":0.4,"avgChangeRate":-0.010091},{"month":9,"riseRate":0.25,"avgChangeRate":-0.081793},{"month":10,"riseRate":0,"avgChangeRate":-0.113594},{"month":11,"riseRate":0.5,"avgChangeRate":-0.121724},{"month":12,"riseRate":0.5,"avgChangeRate":0.09401}],"exchange":"NASDAQ","name":"ImageneBio, Inc.","nameEN":"ImageneBio, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IMA\",market:\"US\",,,undefined,":{"directors":[{"name":"Kristin Yarema","position":"Chief Executive Officer and Director"},{"name":"David Bonita","position":"Director"},{"name":"Jonathan Jian Wang","position":"Director"},{"name":"Otello Stampacchia","position":"Director"},{"name":"Stephen Hui Wang","position":"Director"},{"name":"Weiguo Su","position":"Director"}],"executives":[{"name":"Kristin Yarema","position":"Chief Executive Officer and Director"},{"name":"Erin Butler","position":"Senior Vice President, Finance and Administration and Principal Accounting Officer"},{"name":"Jotin Marango","position":"Chief Financial Officer and Corporate Secretary"},{"name":"Yufang Lu","position":"Chief Medical Officer"}]}}}